Market Tracker

05/22 11:35am ET
81.33
BATS BZX Real-Time Price
As of 11:34am ET
 +0.91 / +1.13%
Today’s Change
66.93
Today|||52-Week Range
83.58
+11.65%
Year-to-Date
Amgen (AMGN) Submits BLA to FDA for Migraine Drug Erenumab
May 19 / Zacks.com - Paid Partner Content
Teva (TEVA) Q1 Earnings In Line, Sales Lag as Copaxone Falls
May 12 / Zacks.com - Paid Partner Content
Bluebird, Kite and Juno Delivering CAR-T Cancer Study Updates to ASCO '17 Meeting
May 17 / TheStreet.com - Paid Partner Content
Ligand Pharmaceuticals (LGND) Q1 Earnings Miss Estimates
May 10 / Zacks.com - Paid Partner Content
Aduro Biotech, Merck Team on Cancer Drug Trial
May 17 / TheStreet.com - Paid Partner Content
Incyte (INCY) Q1 Loss Narrower than Expected, Revenues Beat
May 08 / Zacks.com - Paid Partner Content
GlaxoSmithKline Could Buy Out Partner Novartis
May 15 / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: Merck, Pfizer Report Q1 Earnings, J&J Talc Powder Lawsuit
May 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close80.42
Today’s open81.33
Day’s range81.26 - 81.79
Volume214,995
Average volume (3 months)3,009,989
Market cap$190.1B
Dividend yield3.34%
Data as of 11:34am ET, 05/22/2017

Growth & Valuation

Earnings growth (last year)-61.91%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.07%
Revenue growth (last year)-1.90%
P/E ratio30.7
Price/Sales3.61
Price/Book2.53

Competitors

 Today’s
change
Today’s
% change
PFEPfizer-0.31-0.97%
MRKMerck+0.35+0.55%
SNYSanofi-0.04-0.08%
GSKGlaxoSmithKline-0.30-0.70%
Data as of 11:35am ET, 05/22/2017

Financials

Next reporting dateJuly 18, 2017
EPS forecast (this quarter)$1.19
Annual revenue (last year)$48.4B
Annual profit (last year)$6.7B
Net profit margin13.83%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Joseph Jimenez
Chief Financial Officer
Harry Kirsch
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts